Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Structures of the endophytic microbiota during heart rot development in <i>Abies georgei</i> var. <i>smithii</i>.

Microbiology spectrum·2026
Same author

Controlled encapsulation and droplet size prediction in two-step microfluidic double emulsions.

Lab on a chip·2026
Same author

Time poverty and access-based consumption: Convenience gains and risk blindness.

British journal of psychology (London, England : 1953)·2026
Same author

High-specificity kilobase-level multiplex PCR enabled by graphene oxide-dendrimer-encapsulated gold nanoparticles.

Journal of materials chemistry. B·2026
Same author

Injectable porous nanocomposite microgel assemblies engineered via a triple-dynamic crosslinking strategy for vascularized bone regeneration.

Materials today. Bio·2026
Same author

A novel peak-searching method for multiple radioisotopes based on deep learning.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026
Same journal

RankVar: machine learning-based variant ranking and reinterpretation for rare genetic diseases.

Genome medicine·2026
Same journal

Multi-omics profiles of sex hormone-binding globulin are associated with subclinical atherosclerosis in men with HIV.

Genome medicine·2026
Same journal

Multi-modal data integration reveals functionally credible predictive biomarkers in ovarian cancer.

Genome medicine·2026
Same journal

Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNK.

Genome medicine·2026
Same journal

Identification and functional characterization of regulatory variants in DPP9 associated with COVID-19 severity.

Genome medicine·2026
Same journal

De novo variants in NPTN cause a neurodevelopmental disorder with autism and neuroplastin-PMCA hypofunction.

Genome medicine·2026
查看所有相关文章

相关实验视频

Updated: Jul 9, 2025

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

2.9K

使用单细胞转录组的个性化瘤组合疗法优化.

Chen Tang1, Shaliu Fu1,2, Xuan Jin1

  • 1Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration (Tongji University), Ministry of Education, Orthopaedic Department of Tongji Hospital, Frontier Science Center for Stem Cell Research, Bioinformatics Department, School of Life Sciences and Technology, Tongji University, Shanghai, China.

Genome medicine
|December 2, 2023
PubMed
概括
此摘要是机器生成的。

这项研究介绍了comboSC,这是一种使用单细胞转录组来预测最佳个性化癌症药物组合的计算工具. 它分析免疫微环境以确定协同疗法,加速个性化癌症治疗.

关键词:
两分位的图形图表.组合疗法的优化优化.计算管道中的计算管道.免疫治疗是一种免疫疗法.精准医学是一门精准的医学.一个单细胞RNA-seqq.网络服务器的Web服务器.

更多相关视频

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K
Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties
08:19

Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties

Published on: May 19, 2023

1.7K

相关实验视频

Last Updated: Jul 9, 2025

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

2.9K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K
Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties
08:19

Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties

Published on: May 19, 2023

1.7K

科学领域:

  • 计算生物学 计算生物学
  • 基因组学就是基因组学.
  • 癌症研究 癌症研究

背景情况:

  • 个性化癌症治疗依赖于精确的瘤和免疫微环境的特征.
  • 目前的方法,如体外分析或批量转录组,忽略了瘤异质性和体内免疫微环境.
  • 单细胞转录组对于在个性化癌症治疗中克服这些局限性至关重要.

研究的目的:

  • 介绍comboSC,一个计算概念验证,用于优化个性化癌症组合疗法.
  • 通过使用单细胞RNA测序来评估他们的免疫微环境来分层患者样本.
  • 为了确定协同作用的药物组合和免疫疗法配对,以实现个性化的临床使用.

主要方法:

  • comboSC使用单细胞RNA测序数据来定量评估免疫微环境.
  • 它集成了体外细胞响应数据,以确定协同作用的药物组合.
  • 双分割图形优化用于对临床使用的药物组合进行优先排序.

主要成果:

  • 组合SC被应用于来自15种癌症类型的119个单细胞转录组数据集.
  • 预测的药物组合使用文献,临床试验数据,细胞系干扰和体内样本进行了验证.
  • 这项研究证明了comboSC用于预测有效的癌症药物组合的可行性.

结论:

  • comboSC是一个可行的计算原型,用于预测个性化癌症药物组合.
  • 它通过减少查时间和节省临床时间来加速个性化瘤治疗.
  • 一个Web服务器和源代码可供临床和研究用户使用.